Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

 		Coronary Artery Disease Phase3 Argentina
Australia
Belgium
Brazil
Canada
Chile
China
France
Hungary
India
Ireland
Italy
Japan
Korea, Republic of
Spain
Switzerland
United Kingdom
United States
View All
 NCT05360446

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

 		Breast Cancer France NCT05697146

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

 		Giant Cell Arteritis, Polymyalgia Rheumatica Phase1 Czechia
Italy
Portugal
Spain
Switzerland
United States
View All
 NCT06130540

Revolade Tablets Specified Drug-use Survey

 		Aplastic Anemia Japan NCT06287268

A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

 		Relapsing Multiple Sclerosis Germany NCT05344469

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

 		Myeloid Diseases Phase1 France
Germany
Hong Kong
Italy
Singapore
Spain
United States
View All
 NCT05552469

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

 		Steroid-refractory Acute Graft Versus Host Disease Phase4 China NCT06462469

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

 		Breast Cancer Phase1, Phase2 Australia
Canada
China
France
Korea, Republic of
Singapore
Spain
View All
 NCT06247995

Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study

 		Multiple Sclerosis Switzerland NCT05285904

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

 		Aortic Stenosis Phase2 Austria
Canada
Czechia
Denmark
France
Germany
Israel
Italy
Portugal
Spain
Switzerland
United Kingdom
United States
View All
 NCT05646381